跳至主要内容
临床试验/CTRI/2021/11/037872
CTRI/2021/11/037872尚未招募2 期

Randomized Controlled Trial of Mycofenolate Mofetil versus Standard of Care for COVID Related Interstitial Lung Disease -A Pilot Projecct

Institute of Postgraduate Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • RT-PCR confirmed case of COVID 19 infection.
  • Patients with confirmed case of COVID 19 with persistence of lung lesion on HRCT after 6weeks of infection
  • Normal hepatic and renal function
  • Participants can understand the study and sign informed consent for the study.

排除标准

  • Previous or concurrent malignancies
  • Any previous immunosuppressive therapy/ radiotherapy/ or HIV
  • Medical or psychiatric conditions that compromise the patients ability to give informed consent.

研究者

发起方
Institute of Postgraduate Medical Education and Research

相似试验

进行中(未招募)
1 期
A randomised clinical trial of mycophenolat mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitis
EUCTR2006-001663-33-ATVasculitis Clinical Trial Office140
已完成
不适用
A Randomised Controlled Trial of Mycophenolate Mofetil (MMF) in Patients with Immunoglobulin A (IgA) Nephropathy (IgAN)IgA NephropathyUrological and Genital Diseases
ISRCTN62574616Medical City Dallas Hospital (USA)100
进行中(未招募)
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitis
EUCTR2006-001663-33-DECambridge University Hospitals NHS Foundation Trust140
进行中(未招募)
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitis. Wegener´s granulomatosis (WG) and microscopic polyangiitis (MPA) are primary systemic vasculitides associated with ANCA
EUCTR2006-001663-33-SECambridge University Hospitals NHS Foundation Trust140
进行中(未招募)
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis. - MYCYCPatient ayant une vascularite associée aux ANCAMedDRA version: 8.1Level: PTClassification code 10047115Term: Vasculitis
EUCTR2006-001663-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)140